Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K. - McCourt CK; Wei Z; Kalinsky K; Gray R; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Force J; Pakanati A; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2025)